NCT04842422View on ClinicalTrials.gov

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

PHASE4CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

August 23, 2021

Study Completion Date

August 23, 2021

Conditions

Actinic Keratoses

Interventions

DRUG

Imiquimod 3.75% Cream

Imiquimod 3.75% Cream

Trial Locations (1)

8010

Universitätsklinik für Dermatologie und Venerologie, Graz

All Listed Sponsors

lead

Medical University of Graz

OTHER